🔎 Trials Near Me

Home › Aneurysms › California › Los Angeles

Aneurysms clinical trials in Los Angeles, CA

5 studies for Aneurysms are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms

Recruiting
  • University of Southern California Health Sciences / Keck Hospital of USC, Los Angeles
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07143019

A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta

Recruiting
  • Keck Medicine of USC, Los Angeles
  • Cedars-Sinai Medical Center, Los Angeles
Ages 18 and older · All sexes · Updated Jul 27, 2026 · NCT07078383

Endovascular AAA Intervention Using the GORE® EXCLUDER® Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis

RecruitingObservational study
  • University of Southern California, Los Angeles
  • University of Southern California, Los Angeles
Ages 18 and older · All sexes · Updated Feb 5, 2026 · NCT06218875

Frailty and Physician Modified Fenestrated Endograft for Thoracoabdominal Aortic Pathologies

Recruiting
  • Keck Hospital of University of Southern California, Los Angeles
Ages 18 and older · All sexes · Updated Jul 1, 2024 · NCT04524247

Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders

RecruitingObservational study
  • Cedars-Sinai Medical Center, Los Angeles
Ages 18 and older · All sexes · Updated Feb 8, 2023 · NCT02910180

About Aneurysms

An aneurysm is a bulge in the wall of an artery. It can develop and grow for years without causing any symptoms. Learn about tests and treatment.

More about Aneurysms on MedlinePlus

Aneurysms trials in other cities

Other studies in Los Angeles

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.